1. Stratton IMAdler AI, Neil HAWet al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ2000;321:405–12.
2.
2. Pouliot MCDespres JP, Lemieux Set al.Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol1994;73:460–8.
3.
3. Klein SAllison DB, Heymsfield SBet al.A consensus statement from Shaping America's Health: Association for weight management and obesity prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care2007;30:1647–52.
4.
4. Alberti KGZimmet P, Shaw JIDF Epidemiology Task Force Consensus Group: The metabolic syndrome – a new worldwide definition. Lancet2005;366:1059–62.
5.
5. IDF Task Force on Clinical Practice Guidelines: Global guideline for type 2 diabetes. International Diabetes Federation, 2005.
6.
6. American Diabetes Association: Standards of medical care in diabetes-2007. Diabetes Care2007;30:S4–S41.
7.
7. Kahn RBuse J, Ferrannini E, Stern M.The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care2005;28:2289–304.
8.
8. Scheen AJVan Gaal LG, Despres JP, Pi-Sunyer X, Golay A, Hanotin C.Rimonabant improves cardiometabolic risk profile in obese or over-weight subjects: Overview of RIO studies. Revue Medicale Suisse2006;2:1916–23.